225Ac-LNC1011

· First Affiliated Hospital of Fujian Medical University

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for 225Ac-LNC1011, covering 2025-08-12 to 2026-01-23. Get the full timeline:

Most recent: Clinical Trial Update: Sequential Study of 225Ac-LNC1011 in the Treatment of Metastatic Castration-Resistant Prostate Cancer [Phase 1, Phase 2]

See pricing